Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|May 9, 2018
Post-operative complications in elderly onset inflammatory bowel disease: a population-based studyS-C Sacleux, H Sarter, M Fumery, et al.
Mucosal Immunology|October 8, 2015
Role of mannose-binding lectin in intestinal homeostasis and fungal eliminationL Choteau, M Parny, N François, et al.
Gut|August 5, 2016
Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based studyA Hochart, C Gower-Rousseau, H Sarter, et al.
Clinical and Experimental Immunology|January 24, 2014
Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseasesN-E Serriari, M Eoche, L Lamotte, et al.
Journal of Crohn'S & Colitis|April 29, 2017
Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]E Bequet, H Sarter, M Fumery, et al.
Journal of Crohn'S & Colitis|February 26, 2022
How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort StudyC Cottron, X Treton, R Altwegg, et al.
Alimentary Pharmacology & Therapeutics|October 14, 2017
Efficacy and safety of golimumab in Crohn's disease: a French national retrospective studyC Martineau, B Flourié, P Wils, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 28, 2024
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter studyM Hupé, A Streichenberger, P Wils, et al.
Journal of Crohn'S & Colitis|May 5, 2022
Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort StudyF Poullenot, A Amiot, M Nachury, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2018
Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experienceP Wils, Y Bouhnik, P Michetti, et al.
Pageof 3